BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, January 12, 2026
See today's BioWorld
Home
» Other news to note for Sept. 29, 2020
To read the full article
sign up for free
or
sign in
.
Other news to note for Sept. 29, 2020
Sep. 29, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acasti, Aclipse, Advaxis, Annovis, Arbor, Aspargo, Baselaunch, Better Plant, CASI, Celyad, Creative Medical, Cristal, Enesi, EV, Farmalider, Field Trip Psychedelics, Fosun, Global Cancer Technology, J&J, Juventas, Koligo, Lexaria, Lifesci Acquisition, Luca, M8, Merck, Moleculin, Navrogen, Neuropore, Orgenesis, Polyphor, Psygen, Sema4, Soricimed, Sorrento, South Rampart, Tonix, Vincera, Vor.
BioWorld
Briefs
Other news to note
Coronavirus